Behavioral Nudges for Diabetes Prevention (BEGIN) Trial in Primary Care

NAActive, not recruitingINTERVENTIONAL
Enrollment

960

Participants

Timeline

Start Date

March 21, 2022

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
PreDiabetes
Interventions
BEHAVIORAL

Decision Aid intervention

"* Displays information about the benefits and risks of ILI and metformin~* Asks open-ended questions: What am I willing to do to prevent T2D? and What do I need to prevent T2D?~* Prompts patients to commit to immediate next steps~* Health educator schedules interested patients for first ILI session or sends message to provider about patients' interest in starting metformin, if chosen"

BEHAVIORAL

Text Messaging intervention

"* Defines prediabetes and includes individualized A1c values~* Present benefits and risks of intensive lifestyle intervention and metformin~* States that other prediabetic Erie patients are adopting intensive lifestyle intervention and metformin~* Encourages initiating intensive lifestyle intervention or discussing metformin with provider~* Include selected behavioral content from diabetes prevention program~* Initial message with automatic opt-in, allows opt-out for messages~* Subsequent messages include: information about T2D risk and treatments; prompts to directly schedule intensive lifestyle intervention or office visit to discuss metformin; selected behavioral content from diabetes prevention programming"

BEHAVIORAL

Usual Care

Patients receiving care at non-intervention clinic sites will not be exposed to treatment intervention.

Trial Locations (1)

60611

Northwestern University, Chicago

All Listed Sponsors
lead

Northwestern University

OTHER